Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	1236199-60-2
Formula :	C₁₉H₂₈Cl₂N₄O₂
M.W :	415.36
SMILES Code :	O=C(NO)CCCCCCC1=NC2=CC(N(CCCl)CCCl)=CC=C2N1C
Synonyms :	EDO-s101; NL-101
MDL No. :	MFCD28400036
InChI Key :	GISXTRIGVCKQBX-UHFFFAOYSA-N
Pubchem ID :	46836227

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

A172	1 µM	24 hours	Tinostamustine shifted cell death from autophagy to apoptosis by reducing LC3B and beclin1 expression and increasing p62 expression.	J Hematol Oncol. 2018 Feb 27;11(1):32.
T98G	1 µM	24 hours	Tinostamustine showed significant antitumor effects in MGMT-positive T98G cells, similar to MGMT-negative cells.	J Hematol Oncol. 2018 Feb 27;11(1):32.
U251MG	1 µM	24 hours	Tinostamustine enhanced the effects of radiotherapy by reducing γH2AX expression and increasing its disappearance time, indicating reduced DNA repair.	J Hematol Oncol. 2018 Feb 27;11(1):32.
U87MG	1 µM	24 hours	Tinostamustine exhibited stronger antiproliferative and pro-apoptotic effects compared to vorinostat and bendamustine alone, similar to their combination, irrespective of MGMT expression.	J Hematol Oncol. 2018 Feb 27;11(1):32.
NCI-H929 cell line	1 and 2.5 µM	48 hours	To evaluate the effect of Tinostamustine on CD38 expression, results showed no increase in CD38 surface expression.	Int J Mol Sci. 2024 Apr 26;25(9):4718
U266 cell line	1 and 2.5 µM	48 hours	To evaluate the effect of Tinostamustine on CD38 expression, results showed increased CD38 surface expression.	Int J Mol Sci. 2024 Apr 26;25(9):4718
MOLP-8 cell line	1 and 2.5 µM	48 hours	To evaluate the effect of Tinostamustine on CD38 expression, results showed increased CD38 surface expression.	Int J Mol Sci. 2024 Apr 26;25(9):4718
RPMI-8226 cell line	1 and 2.5 µM	48 hours	To evaluate the effect of Tinostamustine on CD38 expression, results showed increased CD38 surface expression.	Int J Mol Sci. 2024 Apr 26;25(9):4718
JJN3 cell line	1 and 2.5 µM	48 hours	To evaluate the effect of Tinostamustine on CD38 expression, results showed increased CD38 surface expression.	Int J Mol Sci. 2024 Apr 26;25(9):4718
MM.1S cell line	1 and 2.5 µM	48 hours	To evaluate the effect of Tinostamustine on CD38 expression, results showed increased CD38 surface expression.	Int J Mol Sci. 2024 Apr 26;25(9):4718
JJN3	1.6–4.8 µM	48 hours	To evaluate the cytotoxicity of EDO-S101 on JJN3 cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all tested MM cell lines, with IC50 values ranging from 1.6 to 4.8 μM.	J Hematol Oncol. 2017 Jun 20;10(1):127.
RPMI-8226	1.6–4.8 µM	48 hours	To evaluate the cytotoxicity of EDO-S101 on RPMI-8226 cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all tested MM cell lines, with IC50 values ranging from 1.6 to 4.8 μM.	J Hematol Oncol. 2017 Jun 20;10(1):127.
U266	1.6–4.8 µM	48 hours	To evaluate the cytotoxicity of EDO-S101 on U266 cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all tested MM cell lines, with IC50 values ranging from 1.6 to 4.8 μM.	J Hematol Oncol. 2017 Jun 20;10(1):127.
MM1R	1.6–4.8 µM	48 hours	To evaluate the cytotoxicity of EDO-S101 on MM1R cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all tested MM cell lines, with IC50 values ranging from 1.6 to 4.8 μM.	J Hematol Oncol. 2017 Jun 20;10(1):127.
MM1S	1.6–4.8 µM	48 hours	To evaluate the cytotoxicity of EDO-S101 on MM cell lines, the results showed that EDO-S101 exhibited significant cytotoxicity in all tested MM cell lines, with IC50 values ranging from 1.6 to 4.8 μM.	J Hematol Oncol. 2017 Jun 20;10(1):127.
U-138 MG glioblastoma cells	1-10 µM	48 hours	Evaluate the effect of Tinostamustine on cell viability, showing concentration-dependent cytotoxicity, with cell viability reduced to 28% at 10 µM.	Int J Mol Sci. 2025 Jan 14;26(2):661
U-87 MG astrocytoma cells	1-10 µM	48 hours	Evaluate the effect of Tinostamustine on cell viability, showing concentration-dependent cytotoxicity, with cell viability reduced to 48.6% at 10 µM.	Int J Mol Sci. 2025 Jan 14;26(2):661
OCI-LY10	0.625-4.994 μM	48 hours	NL101 significantly inhibited B cell lymphoma proliferation through induction of cell cycle arrest and apoptosis.	Theranostics. 2021 Jan 19;11(7):3439-3451.
Ramos	0.625-4.994 μM	48 hours	NL101 significantly inhibited B cell lymphoma proliferation through induction of cell cycle arrest and apoptosis.	Theranostics. 2021 Jan 19;11(7):3439-3451.

NSG mice	Subcutaneous plasmacytoma model	Intravenous (tinostamustine), intraperitoneal (daratumumab)	30 mg/kg (tinostamustine), 8 mg/kg (daratumumab)	Weekly for 4 consecutive weeks	To evaluate the anti-myeloma effect of Tinostamustine in combination with daratumumab, results showed that the combination significantly delayed tumor growth and improved mice survival.	Int J Mol Sci. 2024 Apr 26;25(9):4718
Female CD1-nu/nu mice	U251MG, U87MG, and T98G subcutaneous xenograft models	Intravenous injection	60 mg/kg	Administered on days 1, 8, and 15, with a 28-day cycle	Tinostamustine monotherapy reduced tumor weight and showed synergistic effects when combined with radiotherapy, significantly prolonging progression-free survival and overall survival.	J Hematol Oncol. 2018 Feb 27;11(1):32.
CB17-SCID mice	Subcutaneous plasmacytoma model	Intravenous injection	60 mg/kg	Once weekly for 21 days	To evaluate the anti-tumor activity of EDO-S101 in vivo in a subcutaneous plasmacytoma model, the results showed that EDO-S101 significantly inhibited tumor growth and significantly prolonged the survival of mice.	J Hematol Oncol. 2017 Jun 20;10(1):127.

{[proInfo.proName]}

CAS No.: 1236199-60-2

{[proInfo.proName]}

CAS No.: 1236199-60-2

Alternative Products

Product Details of Tinostamustine

Safety of Tinostamustine

Related Pathways of Tinostamustine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT05432375	Glioblastoma Multiforme	EARLY_PHASE1	ACTIVE_NOT_RECRUITING	2024-11-30	Hospital Universitario Vall d'... More >>Hebron, Barcelona, Spain, Barcelona, Spain\|Hospital Universitario Ramón y Cajal, Madrid, Spain, Madrid, Spain\|South Texas Accelerated Research Therapeutics (START), Madrid, Spain\|Kantonsspital, St Gallen, Switzerland\|University Hospital, Zürich, Switzerland Less <<
NCT03903458	Malignant Melanoma	PHASE1	UNKNOWN	2024-03-15	Kantonsspital Graubünden, Chur... More >>, 7000, Switzerland\|Cantonal Hospital St.Gallen, St.Gallen, 9007, Switzerland Less <<
NCT02576496	Hematological Malignancies\|Mul... More >>tiple Myeloma\|Hodgkin's Lymphoma\|Cutaneous T Cell Lymphoma Less <<	PHASE1	COMPLETED	2023-11-21	Mayo Clinic, Phoenix, Arizona,... More >> 85054, United States\|Mayo Clinic Cancer Center, Jacksonville, Florida, 32224, United States\|Columbia University Medical Center, New York, New York, 10019, United States\|University Hospitals Cleveland Seidman Cancer Center, Cleveland, Ohio, 44106, United States\|CHU de Caen, Caen, CS 3001, France\|CHU ESTAING Service de thérapie Cellulaire et hématologique Clinique, Clermont Ferrand, 63000, France\|CHU Lille Service des Maladies du Sang, Lille, 59037, France\|Hopital Haut Leveque, Pessac, 33604, France\|Centre hospitalier Lyon Sud, Pierre Bénite, 69495, France\|University Hospital of Ulm, Department of Internal Medicine III, Ulm, 89081, Germany\|Institute of Hematology "L. A. Seràgnoli", University of Bologna, Bologna, 40138, Italy\|National Cancer Institute, Fondazione 'G. Pascale', Naples, I-80131, Italy\|VU medisch centrum, Amsterdam, 1081 HV, Netherlands\|Erasmus MC, Rotterdam, 3015 GD, Netherlands\|Institut Català d'Oncologia de Barcelona, Hospitalet de Llobregat, Barcelona, 08908, Spain\|Hospital Universitario de Salamanca, Salamanca, 37007, Spain\|Hospital Universitario Marqués de Valdecilla, Santander, 39008, Spain\|Kantonsspital St.Gallen, St.Gallen, 9007, Switzerland Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.41mL 0.48mL 0.24mL	12.04mL 2.41mL 1.20mL	24.08mL 4.82mL 2.41mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed